@article{AMJ4306,
author = {Kali Zhou and Norah Terrault},
title = {Immune tolerant HBV and HCC: time to revise our tolerance levels for therapy?},
journal = {AME Medical Journal},
volume = {3},
number = {2},
year = {2018},
keywords = {},
abstract = {The immune tolerant (IT) phase, the first phase of chronic hepatitis B virus (HBV) infection, has historically been perceived as a benign period in the natural history of this disease. Perinatal infection leads to a prolonged IT phase, with transition to immune clearance with seroconversion to anti-HBe in the second to third decade, whereas immediate progression to immune clearance usually occurs in newly infected children and adults (1).},
issn = {2520-0518}, url = {https://amj.amegroups.org/article/view/4306}
}